These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 34672671)

  • 1. Can ferritin/lymphocyte percentage ratio, a new indicator, predict the clinical course of COVID-19 cases?
    Aygun H; Eraybar S
    Bratisl Lek Listy; 2021; 122(11):799-804. PubMed ID: 34672671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can ferritin/lymphocyte percentage ratio, a new indicator, predict the clinical course of COVID-19 cases?
    Aygun H; Eraybar S
    Bratisl Lek Listy; 2022; 123(6):395-400. PubMed ID: 35576540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferritin/lymphocyte percentage ratio to predict the severity and mortality of COVID-19.
    Simsek Yurt N; Ocak M
    Malawi Med J; 2023 Sep; 35(3):183-189. PubMed ID: 38362294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte/mean platelet volume ratio, a new marker; is it effective in predicting the prognosis of COVID-19 cases?
    Eraybar S; Yuksel M; Aygun H; Ay MO; Kaya H; Bulut M
    Bratisl Lek Listy; 2021; 122(6):413-417. PubMed ID: 34002615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferritin / albumin ratio could be a new indicator of COVID-19 disease mortality.
    Taşkin Ö; Yilmaz A; Soylu VG; Demir U; Çatan Inan F
    J Infect Dev Ctries; 2023 Jan; 17(1):37-42. PubMed ID: 36795927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patients with acute pancreatitis associated with SARS-CoV-2 (COVID-19); The importance of lipase/lymphocyte ratio in predicting mortality.
    Haydar FG; Otal Y; Avcioglu G
    Bratisl Lek Listy; 2022; 123(6):428-434. PubMed ID: 35576544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Some Laboratory Parameters Predict Mortality in COVID-19?
    Nurlu N; Ozturk OO; Cat A; Altunok ES; Gumus A
    Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
    Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
    Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of D-dimer in hospitalized COVID-19 patients.
    Korkusuz R; Karandere F; Senoglu S; Kocoglu H; Yasar KK
    Bratisl Lek Listy; 2021; 122(11):811-815. PubMed ID: 34672673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
    Deng F; Zhang L; Lyu L; Lu Z; Gao D; Ma X; Guo Y; Wang R; Gong S; Jiang W
    Med Clin (Barc); 2021 Apr; 156(7):324-331. PubMed ID: 33422296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of prognostic value of acute phase reactants in the COVID-19.
    Yormaz B; Ergun D; Tulek B; Ergun R; Korez KM; Suerdem M; Kanat F
    Bratisl Lek Listy; 2020; 121(9):628-633. PubMed ID: 32990010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
    Ramesh J; Reddy SLS; Rajesh M; Varghese J
    Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative.
    Li Y; Yang T; Wang S; Zheng J; Zhou J; Jiang M; Zhou T; Cao Y; Wang H
    Bosn J Basic Med Sci; 2021 Apr; 21(2):235-241. PubMed ID: 32893759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Hormone Levels During Hospital Admission Inform Disease Severity and Mortality in COVID-19 Patients.
    Beltrão FEL; Beltrão DCA; Carvalhal G; Beltrão FEL; Brito ADS; Capistrano KHRD; Bastos IHA; Hecht F; Daltro CHDC; Bianco AC; Gonçalves MDCR; Ramos HE
    Thyroid; 2021 Nov; 31(11):1639-1649. PubMed ID: 34314259
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.
    Bolondi G; Russo E; Gamberini E; Circelli A; Meca MCC; Brogi E; Viola L; Bissoni L; Poletti V; Agnoletti V
    World J Emerg Surg; 2020 Jun; 15(1):41. PubMed ID: 32605582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between the early dynamic changes of lymphocyte and severity of disease in coronavirus disease 2019 patients].
    Zhou J; Zhou Y; Cai J; Lin S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):922-926. PubMed ID: 34590557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity.
    Hammad R; Eldosoky MAER; Fouad SH; Elgendy A; Tawfeik AM; Alboraie M; Abdelmaksoud MF
    Innate Immun; 2021 Apr; 27(3):240-250. PubMed ID: 33646058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.